Inside the Mexican Cartels That Rule Fentanyl Smuggling

Excerpts from article published by The Wall Street Journal, August 31, 2022

With business savvy and growing in Mexico, the Sinaloa and rival Jalisco cartels dominate the market for supplying fentanyl to the U.S. They cornered the market after China cracked down on fentanyl production several years ago and are now churning out bootleg versions of the highly potent synthetic opioid that, in its legal form, is used under prescription to treat severe pain.

Fentanyl’s inexpensive, easy-to-replicate formula has boosted its appeal to criminal networks. It is also fueling an overdose crisis that claimed more than 108,000 lives in the U.S. last year, a record.

“If it were an athlete, people would call it ‘The G.O.A.T.,’ ” said Jim Crotty, who served as deputy chief of staff at the Drug Enforcement Administration from 2019 to 2021. “It is in fact the most pernicious, the most devastating drug that we have ever seen.”

Fentanyl production is simpler than heroin, because it is entirely synthetic and doesn’t require cultivating the poppies needed for heroin. Busts of Mexican labs or large seizures at the border can be quickly offset by new batches without having to wait to harvest crops or pay farmers.

It is also less expensive to make. The plant-based opium needed to produce a kilogram of heroin can cost producers about $6,000, while the precursor chemicals to make a kilogram of fentanyl cost $200 or less, according to Bryce Pardo, associate director of the Rand Corp.’s Drug Policy Research Center, who helped lead a recent bipartisan report on synthetic opioids.
 
Heroin’s profile has been shrinking as fentanyl becomes more available. Some Mexican poppy farmers in the mountains of Sinaloa say they have lost income as cartels shift away from heroin, and have abandoned their fields.

The U.S. attorney’s office in San Diego in June said 26 people were indicted following a two-year investigation into what law-enforcement officials described as a sprawling operation extending from Sinaloa. Drugs seized included methamphetamine, cocaine, heroin and nearly 500,000 fake pills laced with fentanyl, investigators said. The DEA identified alleged couriers, stash-house managers and people who smuggled proceeds back to Mexico.

A separate DEA operation in 2020 led to the arrest of more than 600 alleged Jalisco cartel members in the U.S. That cartel is Mexico’s fastest-growing and most violent. It is fighting with Sinaloa for control of seaports where fentanyl’s chemical ingredients arrive from China as well as routes through the country and border crossings into the U.S.
Illegal fentanyl production has flared in the past. A 2005 fentanyl surge in
parts of the U.S., including the Midwest, led authorities to a single illegal lab in the city of Toluca, near Mexico City. Shutting it down helped stem the problem for a time.

Fentanyl metastasized into a broader crisis in the 2010s, as drugs flowed from China, sometimes through Mexico, and the cartels ramped up their own production. The eastern half of the U.S. was particularly hard-hit as powdered fentanyl was mixed into the heroin supply, sometimes catching users off guard and leading to an increase in fatal overdoses.

Fentanyl’s inexpensive, easy-to-replicate formula has boosted its appeal to criminal networks. It is also fueling an overdose crisis that claimed more than 108,000 lives in the U.S. last year, a record.

The drug often arrives in the form of fake tablets made to look like prescription drugs, including pain pills, law-enforcement authorities said. The DEA believes these dupes—often stamped to look like real 30 milligram oxycodone pills—are aimed at driving prescription drug users toward an illicit, cartel-made product.
The pills are so ubiquitous that they have been falling in price, creating pressure on the cartels to roll out new products, according to a 27-year-old fentanyl producer who runs a clandestine lab in Culiacán. He said he and a partner are experimenting with a new version meant to be 30% more potent than the typical fake oxycodone tablets, known as M30s.

The new pills, colored pink, yellow and green, have the shape of a skull, an iconic Mexican folkloric image, and don’t try to mimic real medication. They are also made with butter flavoring so that, when melted on foil with a flame, the pills leave a golden trail and smell like caramel popcorn, telltale signs of quality, said the producer. He said he has made as many as one million pills in a week. Another worker in his lab had to periodically stop one of their machines—a $4,000, Chinese made pill press—to clear jams as it ran on a recent, humid day.

“The M30 is not working very well. Everybody is making them,” the producer said. The new pill, he said, “will generate a lot of demand.”

The drug often arrives in the form of fake tablets made to look like prescription drugs, including pain pills, law-enforcement authorities said. The DEA believes these dupes—often stamped to look like real 30 milligram oxycodone pills—are aimed at driving prescription drug users toward an illicit, cartel- made product. The pills are so ubiquitous that they have been falling in price, creating pressure on the cartels to roll out new products, according to a 27-year-old fentanyl producer who runs a clandestine lab in Culiacán. He said he and a partner are experimenting with a new version meant to be 30% more potent than the typical fake oxycodone tablets, known as M30s.

The new pills, colored pink, yellow and green, have the shape of a skull, an iconic Mexican folkloric image, and don’t try to mimic real medication. They are also made with butter flavoring so that, when melted on foil with a flame, the pills leave a golden trail and smell like caramel popcorn, telltale signs of quality, said the producer. He said he has made as many as one million pills in a week. Another worker in his lab had to periodically stop one of their machines—a $4,000, Chinese-made pill press—to clear jams as it ran on a recent, humid day.  “The M30 is not working very well. Everybody is making them,” the producer said. The new pill, he said, “will generate a lot of demand.”